Corticosteroids may restore sense of smell in COVID-19 patients

COVID-19 is known to cause loss of smell in certain patients. While this symptom is generally temporary, approximately 10% of patients may suffer from it for 6 months or more.

Scientists urge vaccination funding as Ghana and Nigeria grapple with anthrax outbreaks

As Ghana and Nigeria grapple with outbreaks of anthrax, scientists say governments must prioritize funds for vaccination to prevent a re-emergence of the disease across

August 18, 2023

iAnthus Arizona Asset Sale Yields $36.5 Million

iAnthus Strengthens Portfolio with $36.5M Sale of Select Arizona Assets to Sonoran Roots Transaction Supports iAnthus’ Focus on Key Growth Markets While Maintaining Presence in

February 7, 2025

Awakn Announces Positive Outcome of Pre-IND Meeting with FDA for AWKN-002 in Alcohol Use Disorder | Psychedelic Invest

Toronto, Ontario–(Newsfile Corp. – January 20, 2025) – Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) (“Awakn” or the “Company”), a clinical-stage biotechnology company

January 24, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.